This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Etsy, Inc.
Intellia Therapeutics, Inc.
Nutrien Ltd.
Ionis Pharmaceuticals, Inc.
Pentair plc

Etsy, Inc.

ETSY

0.00

Intellia Therapeutics, Inc.

NTLA

0.00

Nutrien Ltd.

NTR

0.00

Ionis Pharmaceuticals, Inc.

IONS

0.00

Pentair plc

PNR

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Stifel analyst Nathan Jones downgraded Pentair PLC (NYSE:PNR) from Buy to Hold and cut the price target from $103 to $65. Pentair shares closed at $64.33 on Wednesday. See how other analysts view this stock.
  • Wolfe Research analyst Andy Chen downgraded Intellia Therapeutics Inc (NASDAQ:NTLA) from Peer Perform to Underperform and announced a $9 price target. Intellia Therapeutics shares closed at $13.04 on Wednesday. See how other analysts view this stock.
  • BTIG analyst Marvin Fong downgraded Etsy Inc (NYSE:ETSY) from Buy to Neutral. Etsy shares closed at $85.74 on Wednesday. See how other analysts view this stock.
  • Jefferies analyst Laurence Alexander downgraded Nutrien Ltd (NYSE:NTR) from Buy to Hold and slashed the price target from $96 to $63. Nutrien shares closed at $68.33 on Tuesday. See how other analysts view this stock.
  • Wolfe Research analyst Andy Chen downgraded Ionis Pharmaceuticals Inc (NASDAQ:IONS) from Outperform to Peer Perform. Ionis Pharmaceuticals shares closed at $54.73 on Wednesday. See how other analysts view this stock.

Considering buying ETSY stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.